Huang CF(黃志芳), Wang SF, Yeh YC, Lee MH, Chen SC, & Koo M(2012). Prevalence and factors associated with metabolic syndrome in middle-aged adults and elderly in southern Taiwan. Tzu Chi Nursing Journal 11(1):72-84.
Huang YC(黃彥傑), Huang CF(黃志芳), Chang KC, Hung SF, Wang JH, Hung CH, Chen CH, Tseng PL, Kee KM, Yen YH, Tsai PS RN, Tsai CC and Lu SN(盧勝男). Community-based Screening for Hepatocellular Carcinoma in Elderly Residents in a Hepatitis B and C Endemic Area. J Gastroenterol Hepatol. 2011 Jan;26(1):129-34
Huang CF(黃志芳), Chen CT, Wang PM, Koo M*. Betel-quid and alcohol use were associated with lipid accumulation product among male factory workers in Taiwan. Int Health. 2015 May;7(3):218-22. (SCI;IF=1.664)
Chiang IH(江怡慧), Chang WN, Lin WC, Chuang YC, Chang KC, Tsai NW, Liou CW, Sun TK, Loke SS(駱聰成), Chen CT(陳朝棟), Huang CF(黃志芳), Huang WC(黃偉城), Wang PM(王培銘), Lu CH(盧成憲). Risk factors for seizures after first-time ischemic stroke by magnetic resonance imaging. Acta Neurol Taiwan. 2010 Mar;19(1):26-32
Malcolm Koo, Yi-Ya Chang , Ming-Ho Lee , Chih-Fang Huang(黃志芳),Shang-Chi Chen , Yueh-Chiao Yeh.Factors Associated with the Use of Complementary and Alternative Medicine in Middle-Aged Adults and Elderly. Taiwan Geriatr Gerontol 2011; 6(1): 29-41
11. Loke SS, Rau KM, Huang CF(黃志芳). Impact of combined hospice care on terminal cancer patients. J Palliat Med. 2011 Jun;14(6):683-7
Loke SS, Rau KM, Huang CF(黃志芳). Impact of combined hospice care on terminal cancer patients. J Palliat Med. 2011 Jun;14(6):683-7
Liang CM, Chiu CH, Wang HM, Tai WC, Yao CC, Tsai CE, Kuo CM, Wu KL, Lee CH*, Tsai KL, Huang CF(黃志芳), Chuah SK*. First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan. BioMed Research International Volume 2017, Article ID 3762194 . doi.org/10.1155/2017/3762194 (SCI;IF=2.197)
Liang CM, Kuo MT, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Wang HM, Yao CC, Tsai CE, Wang YK, Wang JW, Huang CF(黃志芳), Wu DC, Chuah SK*. First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease. World J Gastroenterol. 2017 Dec 21; 47:8395-8404. (SCI;IF=3.411)
Pan BL, Huang CF(黃志芳), Chuah SK, Chiang JC, Loke SS*. Relationship between Helicobacter pylori infection and bone mineral density: a retrospective cross-sectional study. BMC Gastroenterology, 2018 Apr 24;18(1):54. (SCI;IF=2.252)
Lim IW, Chiang JC, Wang PM, Loke SS, Chen CT, Huang KS, Huang CF*(黃志芳). Effects of Integrated Care for Severely Disabled Residents Living in a Long-Term Care Facility in Kaohsiung City. Taiwan J Fam Med，2018,28(2):55-64.
Wang JW, Tseng KL, Hsu CN, Liang CM, Tai WC, Ku MK, Hung TH, Yuan LT, Nguang SH, Yang SC, Wu CK, Chiu CH, Tsai KL, Chang MW, Huang CF(黃志芳), Hsu PI, Wu DC*, Chuah SK*.(Corresponding author). Association between Helicobacter pylori eradication and the risk of coronary heart diseases PLoS One. 2018 Jan 2;13(1):e0190219. (SCI;IF=2.776)
Wang PM, Hsu CW, Liu CT, Lai TY, Tzeng FL, Huang CF(黃志芳)*. Effect of acupressure on constipation in patients with advanced cancer. Support Care Cancer. (2019)27:3473-3478 (SCI;IF=2.754)
Chiang HH, Wu DC, Hsu PI, Kuo CH, Tai WC, Yang SC, Wu KL, Yao CC, Tsai CE, Liang CM*, Wang YK, Wang JW, Huang CF(黃志芳), Chuah SK; Taiwan Acid-Related Disease Study Group. Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: A prospective randomized trial. Drug Des Devel Ther. 2019 Apr 26;13:1347-1356.(SCI;IF=3.208)
Yao CC, Kuo CM, Hsu CN, Yang SC, Wu CK, Tai WC, Liang CM*, Wu KL, Huang CF(黃志芳), Bi KW, Lee CH, Chuah SK. First line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus. Infect Drug Resist. 2019 May 29;12:1425-1431. (SCI;IF=3.000)
Tai WC, Liang CM, Bi KW, Kuo CM*, Lu LS, Wu CK, Yang SC, Kuo YH, Lee CH, Huang CF(黃志芳), Hsu CN, Hsu PI, Wu DC, Hu TH, Wu KL, Chuah SK*. A Comparison between Dexlansoprazole MR-based and Lansoprazole-based Non-bismuth Quadruple (Concomitant）Therapy for First Line Helicobacter Pylori Eradication: A Prospective Randomized Trial. Infect Drug Resist. 2019 Sep 16; 12:2923-2931.(SCI;IF=3.000)
